Help pets bounce back from lameness and joint issues with a single injection of Spryng™ with OsteoCushion™ Technology.
Spryng™ with OsteoCushion™ Technology is an innovative intra-articular injectable veterinary medical device that is designed to prevent the occurrence and re-occurrence of joint pain from loss of cartilage or tissue-bone mechanical malfunction by augmenting and reinforcing cartilage to assist in the normalization of joint function.
Spryng™ has been initially used in over 600 animals (dogs, horses, cats, rabbits). An independent safety study, performed by a reputable equine organization, demonstrated product safety following injection of the product in over 70 joints in more than 20 horses. Additional efficacy studies are in progress with a nationally recognized university and a renowned private clinical study institution.
A single Spryng™ injection provides both immediate joint protection and helps protect the joint from further injury, unlike other products that only treat symptoms (NSAIDs, corticosteroids, monoclonal antibodies, radiation, etc.).
Spryng™ with OsteoCushion™ Technology is a type of biomaterial that is a naturally derived combination of two purified proteins; collagen and elastin bound together in a proprietary process that is used to augment synovial fluid. Spryng™ also works as a cartilage reinforcement for osteoarthritis and other joint issues. It can be used to buffer mechanical malfunction in joints to provide a soft, lubricating, and elastic cushion for the normalization of joint function. Spryng™ is classified as a veterinary medical device. It provides long-lasting relief from the degradation of joint associated with osteoarthritis.
This will depend on the individual animal . . . its underlying issues and health history. In most cases, the animal will respond almost immediately to administration and return to their previous activities, although it may take 7 to 14 days to see the expected response.
As a veterinary medical device, Spryng™ does not exert pharmacological, chemical, or metabolic injectable devices action. Spryng™ has been used with other products commonly used for osteoarthritis in canines and lameness in horses without known adverse effects. While Spryng™ is a primary tool for managing osteoarthritis, it is one of many excellent tools that should be used in a multi-modal approach.